Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 308

1.

Treatment of vitamin D deficiency within a large integrated health care delivery system.

Stratton-Loeffler MJ, Lo JC, Hui RL, Coates A, Minkoff JR, Budayr A.

J Manag Care Pharm. 2012 Sep;18(7):497-505.

2.

Prescription ergocalciferol dosing for vitamin D repletion: a retrospective evaluation.

Vande Griend JP, McQueen RB, Linnebur SA, Vondracek SF.

Pharmacotherapy. 2012 Feb;32(2):135-41. doi: 10.1002/PHAR.1052.

PMID:
22392422
3.

Evaluating Vitamin D Repletion Regimens and Effects in Veteran Patients.

Aterrado S, Ono G, Kanehira-Mar S, Meier J, Swislocki A.

Ann Pharmacother. 2015 Sep;49(9):969-77. doi: 10.1177/1060028015591034. Epub 2015 Jun 23.

PMID:
26104054
4.

Prevalence of vitamin D [25(OH)D] deficiency and effects of supplementation with ergocalciferol (vitamin D2) in stage 5 chronic kidney disease patients.

Blair D, Byham-Gray L, Lewis E, McCaffrey S.

J Ren Nutr. 2008 Jul;18(4):375-82. doi: 10.1053/j.jrn.2008.04.008. Erratum in: J Ren Nutr. 2009 Mar;19(2):195.

PMID:
18558303
5.

Comparative efficacy and safety of different doses of ergocalciferol supplementation in patients with metabolic syndrome.

Sansanayudh N, Wongwiwatthananukit S, Phetkrajaysang N, Krittiyanunt S.

Int J Clin Pharm. 2014 Aug;36(4):771-8. doi: 10.1007/s11096-014-9958-1. Epub 2014 May 23.

PMID:
24853094
6.

Very high-dose ergocalciferol is effective for correcting vitamin D deficiency in children and young adults with cystic fibrosis.

Boas SR, Hageman JR, Ho LT, Liveris M.

J Cyst Fibros. 2009 Jul;8(4):270-2. doi: 10.1016/j.jcf.2009.04.004. Epub 2009 May 15.

7.

Evaluation of vitamin D repletion regimens to correct vitamin D status in adults.

Pepper KJ, Judd SE, Nanes MS, Tangpricha V.

Endocr Pract. 2009 Mar;15(2):95-103.

8.

Differences in outcomes between cholecalciferol and ergocalciferol supplementation in veterans with inflammatory bowel disease.

Youssef D, Bailey B, Atia A, El-Abbassi A, Manning T, Peiris AN.

Geriatr Gerontol Int. 2012 Jul;12(3):475-80. doi: 10.1111/j.1447-0594.2011.00798.x. Epub 2012 Jan 10.

PMID:
22233182
9.

A Retrospective Evaluation of Response to Vitamin D Supplementation in Obese Versus Nonobese Patients.

Bryant GA, Koenigsfeld CF, Lehman NP, Smith HL, Logemann CD, Phillips KT.

J Pharm Pract. 2015 Dec;28(6):543-7. doi: 10.1177/0897190014544822. Epub 2014 Aug 14.

PMID:
25124377
10.

Prevalence and correction of 25(OH) vitamin D deficiency in peritoneal dialysis patients.

Shah N, Bernardini J, Piraino B.

Perit Dial Int. 2005 Jul-Aug;25(4):362-6.

PMID:
16022093
11.

Effects of a 10-day course of a high dose calciferol versus a single mega dose of ergocalciferol in correcting vitamin D deficiency.

Melhem SJ, Aiedeh KM, Hadidi KA.

Ann Saudi Med. 2015 Jan-Feb;35(1):13-8. doi: 10.5144/0256-4947.2015.13.

12.

Cholecalciferol v. ergocalciferol for 25-hydroxyvitamin D (25(OH)D) repletion in chronic kidney disease: a randomised clinical trial.

Wetmore JB, Kimber C, Mahnken JD, Stubbs JR.

Br J Nutr. 2016 Dec;116(12):2074-2081. doi: 10.1017/S000711451600427X. Epub 2017 Jan 9.

PMID:
28065190
13.

Dose-response effect of ergocalciferol therapy on serum 25-hydroxyvitamin D concentration during critical illness.

Dickerson RN, Berry SC, Ziebarth JD, Swanson JM, Maish GO 3rd, Minard G, Brown RO.

Nutrition. 2015 Oct;31(10):1219-23. doi: 10.1016/j.nut.2015.03.008. Epub 2015 Apr 4.

PMID:
26213135
14.

Prevalence of 25-OH vitamin D deficiency in a population of hemodialysis patients and efficacy of an oral ergocalciferol supplementation regimen.

Porter A, Gilmartin C, Srisakul U, Arruda J, Akkina S.

Am J Nephrol. 2013;37(6):568-74. doi: 10.1159/000351185. Epub 2013 May 30.

15.

Insulin secretion and sensitivity in healthy adults with low vitamin D are not affected by high-dose ergocalciferol administration: a randomized controlled trial.

Mitchell DM, Leder BZ, Cagliero E, Mendoza N, Henao MP, Hayden DL, Finkelstein JS, Burnett-Bowie SA.

Am J Clin Nutr. 2015 Aug;102(2):385-92. doi: 10.3945/ajcn.115.111682. Epub 2015 Jul 8.

16.

Adequacy of vitamin D replacement in severe deficiency is dependent on body mass index.

Lee P, Greenfield JR, Seibel MJ, Eisman JA, Center JR.

Am J Med. 2009 Nov;122(11):1056-60. doi: 10.1016/j.amjmed.2009.06.008.

PMID:
19854337
17.

Calculated free and bioavailable vitamin D metabolite concentrations in vitamin D-deficient hip fracture patients after supplementation with cholecalciferol and ergocalciferol.

Glendenning P, Chew GT, Inderjeeth CA, Taranto M, Fraser WD.

Bone. 2013 Oct;56(2):271-5. doi: 10.1016/j.bone.2013.06.012. Epub 2013 Jun 20.

PMID:
23792937
18.

Chronic kidney disease and diabetes mellitus predict resistance to vitamin D replacement therapy.

Alshayeb HM, Wall BM, Showkat A, Mangold T, Quarles LD.

Am J Med Sci. 2013 Apr;345(4):314-20. doi: 10.1097/MAJ.0b013e31826af2d3.

PMID:
23221508
20.

Ergocalciferol versus Cholecalciferol for Nutritional Vitamin D Replacement in CKD.

Mangoo-Karim R, Da Silva Abreu J, Yanev GP, Perez NN, Stubbs JR, Wetmore JB.

Nephron. 2015;130(2):99-104. doi: 10.1159/000430813. Epub 2015 Jun 2.

PMID:
26044704

Supplemental Content

Support Center